Murphy A, Sawires K, Peltekian S, Helwig M, Macdonald M, Martin-Misener R
Explor Res Clin Soc Pharm. 2024; 16:100538.
PMID: 39634377
PMC: 11615539.
DOI: 10.1016/j.rcsop.2024.100538.
Zullo A, Riester M, DAmico A, Reddy Bhuma M, Khan M, Curry A
JAMA Netw Open. 2024; 7(10):e2438338.
PMID: 39382896
PMC: 11581636.
DOI: 10.1001/jamanetworkopen.2024.38338.
Zullo A, Khan M, Pfeiffer M, Margolis S, Ott B, Curry A
Am J Epidemiol. 2024; 194(3):662-673.
PMID: 38957996
PMC: 11879583.
DOI: 10.1093/aje/kwae168.
Uchiyama Y, Sawai S, Omi T, Yamauchi K, Tamura K, Sakata T
PLoS One. 2023; 18(5):e0285557.
PMID: 37155637
PMC: 10166535.
DOI: 10.1371/journal.pone.0285557.
Muehlan C, Brooks S, Vaillant C, Meinel M, Jacobs G, Zuiker R
Clin Pharmacol Ther. 2022; 111(6):1334-1342.
PMID: 35426136
PMC: 9320895.
DOI: 10.1002/cpt.2592.
The effects of intranasal esketamine on on-road driving performance in patients with major depressive disorder or persistent depressive disorder.
Dijkstra F, van de Loo A, Abdulahad S, Bosma E, Hartog M, Huls H
J Psychopharmacol. 2022; 36(5):614-625.
PMID: 35212235
PMC: 9112620.
DOI: 10.1177/02698811221078764.
Validating lane drifts as a predictive measure of drug or sleepiness induced driving impairment.
Vinckenbosch F, Vermeeren A, Verster J, Ramaekers J, Vuurman E
Psychopharmacology (Berl). 2020; 237(3):877-886.
PMID: 31897572
PMC: 7036056.
DOI: 10.1007/s00213-019-05424-8.
Psychoactive drug consumption among truck-drivers: a systematic review of the literature with meta-analysis and meta-regression.
Dini G, Bragazzi N, Montecucco A, Rahmani A, Durando P
J Prev Med Hyg. 2019; 60(2):E124-E139.
PMID: 31312742
PMC: 6614564.
DOI: 10.15167/2421-4248/jpmh2019.60.2.1245.
A clinical trial on the acute effects of methadone and buprenorphine on actual driving and cognitive function of healthy volunteers.
Strand M, Vindenes V, Gjerde H, Morland J, Ramaekers J
Br J Clin Pharmacol. 2018; 85(2):442-453.
PMID: 30515857
PMC: 6339962.
DOI: 10.1111/bcp.13818.
Comparing the effects of oxazepam and diazepam in actual highway driving and neurocognitive test performance: a validation study.
Jongen S, Vuurman E, Ramaekers J, Vermeeren A
Psychopharmacology (Berl). 2018; 235(4):1283-1294.
PMID: 29500585
PMC: 5869943.
DOI: 10.1007/s00213-018-4844-5.
Medication use and the risk of motor vehicle collisions among licensed drivers: A systematic review.
Rudisill T, Zhu M, Kelley G, Pilkerton C, Rudisill B
Accid Anal Prev. 2016; 96:255-270.
PMID: 27569655
PMC: 5045819.
DOI: 10.1016/j.aap.2016.08.001.
Behavioral and Neurophysiological Signatures of Benzodiazepine-Related Driving Impairments.
Stone B, Correa K, Brown T, Spurgin A, Stikic M, Johnson R
Front Psychol. 2015; 6:1799.
PMID: 26635697
PMC: 4659917.
DOI: 10.3389/fpsyg.2015.01799.
Comparing treatment effects of oral THC on simulated and on-the-road driving performance: testing the validity of driving simulator drug research.
Veldstra J, Bosker W, De Waard D, Ramaekers J, Brookhuis K
Psychopharmacology (Berl). 2015; 232(16):2911-9.
PMID: 25957748
PMC: 4513227.
DOI: 10.1007/s00213-015-3927-9.
Sensitivity and validity of psychometric tests for assessing driving impairment: effects of sleep deprivation.
Jongen S, Perrier J, Vuurman E, Ramaekers J, Vermeeren A
PLoS One. 2015; 10(2):e0117045.
PMID: 25668292
PMC: 4323110.
DOI: 10.1371/journal.pone.0117045.
The effects of acute treatment with ramelteon, triazolam, and placebo on driving performance, cognitive function, and equilibrium function in healthy volunteers.
Miyata A, Iwamoto K, Kawano N, Kohmura K, Yamamoto M, Aleksic B
Psychopharmacology (Berl). 2014; 232(12):2127-37.
PMID: 25533998
DOI: 10.1007/s00213-014-3843-4.
Fatal crashes from drivers testing positive for drugs in the U.S., 1993-2010.
Wilson F, Stimpson J, Pagan J
Public Health Rep. 2014; 129(4):342-50.
PMID: 24982537
PMC: 4037460.
DOI: 10.1177/003335491412900409.
Effects of alcohol hangover on simulated highway driving performance.
Verster J, Bervoets A, de Klerk S, Vreman R, Olivier B, Roth T
Psychopharmacology (Berl). 2014; 231(15):2999-3008.
PMID: 24563184
DOI: 10.1007/s00213-014-3474-9.
Alcohol calibration of tests measuring skills related to car driving.
Jongen S, Vuurman E, Ramaekers J, Vermeeren A
Psychopharmacology (Berl). 2014; 231(12):2435-47.
PMID: 24408210
PMC: 4039994.
DOI: 10.1007/s00213-013-3408-y.
Effects of alcohol on automated and controlled driving performances.
Berthelon C, Gineyt G
Psychopharmacology (Berl). 2013; 231(10):2087-95.
PMID: 24292385
DOI: 10.1007/s00213-013-3352-x.
Lapses of attention as outcome measure of the on-the-road driving test.
Verster J, Bervoets A, de Klerk S, Roth T
Psychopharmacology (Berl). 2013; 231(1):283-92.
PMID: 23975036
DOI: 10.1007/s00213-013-3236-0.